Clinical symptoms in localized renal cell carcinoma reflect its invasive potential: Comparative study between incidentally detected and symptomatic diseases

Urologic Oncology: Seminars and Original Investigations

Volumn 24, Issue 3, 2006, Pages 201-206

  Harada, Ken ichi ^a   Sakai, Iori ^a   Ishimura, Takeshi ^a   Inoue, Taka aki ^a   Hara, Isao ^b   Miyake, Hideaki ^a  

^a HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Clinical symptom; Invasion; Localized renal cell carcinoma; Matrix metalloproteinase

Indexed keywords

GELATINASE A; GELATINASE B; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; PROTEIN ANTIBODY; PROTEIN BCL 2; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER LOCALIZATION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STAINING; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

ADENOCARCINOMA, CLEAR CELL; AGED; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; FEMALE; HUMANS; INCIDENTAL FINDINGS; KI-67 ANTIGEN; KIDNEY NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33646205847     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2005.07.008     Document Type: Article

References (17)

1. Delahunt B., Kittelson J.M., McCredie M.R., et al. Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma. Cancer 94 (2002) 658-664
2. Sweeney J.P., Thornhill J.A., Grainger R., et al. Incidentally detected renal cell carcinoma. Pathological features, survival trends and implications for treatment. Br J Urol 78 (1996) 351-353
3. Pantuck A.L., Zisman A., Rauch M.K., et al. Incidental renal tumors. Urology 56 (2000) 190-196
4. Tsui K.H., Shvarts O., Smith R.B., et al. Renal cell carcinoma. Prognostic significance of incidentally detected tumors. J Urol 163 (2000) 426-430
5. Miyake H., Ishimura T., Sakai I., et al. Clinicopathological features of incidentally detected renal cell carcinoma in Japan. UroOncology 3 (2003) 95-98
6. Ishimura T., Sakai I., Hara I., et al. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery. Int J Urol 11 (2004) 264-268
7. Stephenson A.J., Chetner M.P., Rourke K., et al. Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. J Urol 172 (2004) 58-62
8. Zhang X., and Takenaka I. Cell proliferation and apoptosis with bcl-2 expression in renal cell carcinoma. Urology 56 (2000) 510-515
9. Kallakury B.V., Karikehalli S., Haholu A., et al. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin Cancer Res 7 (2001) 3113-3119
10. Slaton J.W., Inoue K., Perrotte P., et al. Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma. Am J Pathol 158 (2001) 735-743
11. Miyake H., Hara S., Arakawa S., et al. Over expression of clusterin is an independent prognostic factor for non-papillary renal cell carcinoma. J Urol 167 (2002) 703-706
12. Uchida T., Gao J.P., Wang C., et al. Clinical significance of p53, mdm2 and bcl-2 proteins in renal cell carcinoma. Urology 59 (2002) 615-620
13. Visapaa H., Bui M., Huang Y., et al. Correlation of Ki-67 and gelsolin expression to clinical outcome in renal cell carcinoma. Urology 61 (2003) 845-850
14. Itoi T., Yamana K., Bilim V., et al. Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients. Br J Cancer 90 (2004) 200-205
15. Zellweger T., Miyake H., July L.V., et al. Chemosensitization of human renal cell cancer using antisense olignucleotides targeting the antiapoptotic gene clusterin. Neoplasia 3 (2001) 360-367
16. Miyake H., Hara I., Yoshimura K., et al. Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential. Cancer Res 56 (1996) 2440-2445
17. Miyake H., Hara I., Gohji K., et al. Relative expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in mouse renal cell carcinoma cells regulates their metastatic potential. Clin Cancer Res 5 (1999) 2824-2829